NBIX
$143.18+1.76%
as of close, Oct 2, 2026
☾ AH $143.18 +1.76%
Neurocrine Biosciences Inc.Stock · Health CareNasdaq Composite 0.03%Russell 1000 0.02%US Stock Market 0.02%Russell 3000 0.02%MSCI World 0.02%MSCI ACWI 0.02%
Neurocrine Biosciences Inc. monthly returns
Neurocrine Biosciences Inc. has averaged 2.14% per month, positive in 51% of months. Month-by-month returns for Neurocrine Biosciences Inc. (NBIX) below, through October 2, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Average month
+2.1%
358 months
Best month
+91.0%
Nov 1999
Worst month
-65.6%
May 2006
Positive months
51%
of all months
Neurocrine Biosciences Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | +0.9% | |
| Sep 2026 | -7.9% | |
| Aug 2026 | -7.7% | |
| Jul 2026 | -1.0% | |
| Jun 2026 | +6.5% | |
| May 2026 | +20.2% | |
| Apr 2026 | -0.1% | |
| Mar 2026 | -0.4% | |
| Feb 2026 | -2.8% | |
| Jan 2026 | -4.1% | |
| Dec 2025 | -6.8% | |
| Nov 2025 | +6.2% | |
| Oct 2025 | +2.0% | |
| Sep 2025 | +0.6% | |
| Aug 2025 | +8.9% | |
| Jul 2025 | +2.0% | |
| Jun 2025 | +2.2% | |
| May 2025 | +14.2% | |
| Apr 2025 | -2.6% | |
| Mar 2025 | -6.8% | |
| Feb 2025 | -21.8% | |
| Jan 2025 | +11.2% | |
| Dec 2024 | +7.7% | |
| Nov 2024 | +5.4% | |
| Oct 2024 | +4.4% | |
| Sep 2024 | -9.3% | |
| Aug 2024 | -10.2% | |
| Jul 2024 | +2.8% | |
| Jun 2024 | +1.7% | |
| May 2024 | -1.5% | |
| Apr 2024 | -0.3% | |
| Mar 2024 | +5.8% | |
| Feb 2024 | -6.7% | |
| Jan 2024 | +6.1% | |
| Dec 2023 | +13.0% | |
| Nov 2023 | +5.1% | |
| Oct 2023 | -1.4% | |
| Sep 2023 | +3.3% | |
| Aug 2023 | +6.9% | |
| Jul 2023 | +8.0% | |
| Jun 2023 | +5.3% | |
| May 2023 | -11.4% | |
| Apr 2023 | -0.2% | |
| Mar 2023 | -1.8% | |
| Feb 2023 | -7.1% | |
| Jan 2023 | -7.1% | |
| Dec 2022 | -6.0% | |
| Nov 2022 | +10.4% | |
| Oct 2022 | +8.4% | |
| Sep 2022 | +1.5% | |
| Aug 2022 | +11.2% | |
| Jul 2022 | -3.4% | |
| Jun 2022 | +4.3% | |
| May 2022 | +3.8% | |
| Apr 2022 | -4.0% | |
| Mar 2022 | +4.3% | |
| Feb 2022 | +13.7% | |
| Jan 2022 | -7.2% | |
| Dec 2021 | +2.3% | |
| Nov 2021 | -21.0% | |
| Oct 2021 | +9.9% | |
| Sep 2021 | +0.7% | |
| Aug 2021 | +2.1% | |
| Jul 2021 | -4.2% | |
| Jun 2021 | +1.1% | |
| May 2021 | +1.8% | |
| Apr 2021 | -2.8% | |
| Mar 2021 | -11.2% | |
| Feb 2021 | -0.2% | |
| Jan 2021 | +14.5% | |
| Dec 2020 | +1.0% | |
| Nov 2020 | -3.8% | |
| Oct 2020 | +2.6% | |
| Sep 2020 | -17.4% | |
| Aug 2020 | -3.3% | |
| Jul 2020 | -1.3% | |
| Jun 2020 | -2.2% | |
| May 2020 | +27.1% | |
| Apr 2020 | +13.4% | |
| Mar 2020 | -8.6% | |
| Feb 2020 | -5.4% | |
| Jan 2020 | -6.9% | |
| Dec 2019 | -7.8% | |
| Nov 2019 | +17.2% | |
| Oct 2019 | +10.4% | |
| Sep 2019 | -9.4% | |
| Aug 2019 | +3.1% | |
| Jul 2019 | +14.2% | |
| Jun 2019 | -0.4% | |
| May 2019 | +17.4% | |
| Apr 2019 | -18.0% | |
| Mar 2019 | +14.0% | |
| Feb 2019 | -12.4% | |
| Jan 2019 | +23.5% | |
| Dec 2018 | -19.1% | |
| Nov 2018 | -17.6% | |
| Oct 2018 | -12.9% | |
| Sep 2018 | +0.0% | |
| Aug 2018 | +22.4% | |
| Jul 2018 | +2.3% | |
| Jun 2018 | +2.1% | |
| May 2018 | +18.7% | |
| Apr 2018 | -2.2% | |
| Mar 2018 | -1.8% | |
| Feb 2018 | -1.2% | |
| Jan 2018 | +10.2% | |
| Dec 2017 | +7.9% | |
| Nov 2017 | +15.7% | |
| Oct 2017 | +1.4% | |
| Sep 2017 | +8.3% | |
| Aug 2017 | +17.8% | |
| Jul 2017 | +4.4% | |
| Jun 2017 | +5.8% | |
| May 2017 | -18.6% | |
| Apr 2017 | +23.3% | |
| Mar 2017 | -1.9% | |
| Feb 2017 | +2.9% | |
| Jan 2017 | +10.9% | |
| Dec 2016 | -16.7% | |
| Nov 2016 | +6.1% |
Monthly total return (since Nov 2021)#
-20%-10%0%10%20%
Nov 2021-21%
Dec 2021+2.3%
Jan 2022-7.2%2022
Feb 2022+14%
Mar 2022+4.3%
Apr 2022-4.0%
May 2022+3.8%
Jun 2022+4.3%
Jul 2022-3.4%
Aug 2022+11%
Sep 2022+1.5%
Oct 2022+8.4%
Nov 2022+10%
Dec 2022-6.0%
Jan 2023-7.1%2023
Feb 2023-7.1%
Mar 2023-1.8%
Apr 2023-0.18%
May 2023-11%
Jun 2023+5.3%
Jul 2023+8.0%
Aug 2023+6.9%
Sep 2023+3.3%
Oct 2023-1.4%
Nov 2023+5.1%
Dec 2023+13%
Jan 2024+6.1%2024
Feb 2024-6.7%
Mar 2024+5.8%
Apr 2024-0.28%
May 2024-1.5%
Jun 2024+1.7%
Jul 2024+2.8%
Aug 2024-10%
Sep 2024-9.3%
Oct 2024+4.4%
Nov 2024+5.4%
Dec 2024+7.7%
Jan 2025+11%2025
Feb 2025-22%
Mar 2025-6.8%
Apr 2025-2.6%
May 2025+14%
Jun 2025+2.2%
Jul 2025+2.0%
Aug 2025+8.9%
Sep 2025+0.56%
Oct 2025+2.0%
Nov 2025+6.2%
Dec 2025-6.8%
Jan 2026-4.1%2026
Feb 2026-2.8%
Mar 2026-0.39%
Apr 2026-0.05%
May 2026+20%
Jun 2026+6.5%
Jul 2026-1.0%
Aug 2026-7.7%
Sep 2026-7.9%
Oct 2026+0.94%
Methodology#
Monthly returns are total returns (dividends reinvested), computed from NBIX's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Neurocrine Biosciences Inc.'s average monthly return?
- Neurocrine Biosciences Inc. (NBIX) has averaged about 2.14% per month, positive in roughly 51% of months. The best month was Nov 1999 (+91.0%) and the worst was May 2006 (-65.6%).
More on Neurocrine Biosciences Inc.
By month for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100